Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

Michael D. Crowther(Cardiff University), Garry Dolton(Cardiff University), Mateusz Legut(Cardiff University), Marine E. Caillaud(Cardiff University), Angharad Lloyd(Cardiff University), Meriem Attaf(Cardiff University), Sarah A. E. Galloway(Cardiff University), Cristina Rius(Cardiff University), Colin Farrell(University of Utah), Barbara Szomolay(Cardiff University), Ann Ager(Cardiff University), Alan L. Parker(Cardiff University), Anna Fuller(Cardiff University), Marco Donia(Herlev Hospital), James McCluskey(The University of Melbourne), Jamie Rossjohn(Australian Research Council), Inge Marie Svane(Herlev Hospital), John D. Phillips(University of Utah), Andrew K. Sewell(Cardiff University)
Nature Immunology
January 20, 2020
10.1038/s41590-019-0578-8
Cited by 260Open Access
Full Text

Abstract

Related Papers

Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana, Ophir Shalem, Feng Zhang|Nature Methods|2014|5.5k
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem, Neville E. Sanjana, Ella Hartenian et al.|Science|2013|5.5k
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles, Aaron M. Newman, Chih Long Liu et al.|Nature Medicine|2015|3.2k
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li, Han Xu, Tengfei Xiao et al.|Genome biology|2014|2.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
Michael R. Betts, Jason M. Brenchley, David A. Price et al.|Journal of Immunological Methods|2003|1.6k